Transition Bio
PrivateLast Round
Series B
Oct 30, 2024
Total Funding Raised
$72.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Transition Bio is a biotechnology company that develops a hypothesis-free drug discovery and diagnostics platform utilizing droplet microfluidic techniques and protein biophysics to analyze biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transition Bio Comparables
Compare Transition Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nereid Therapeutics | 87% | |
| Dewpoint Therapeutics | 86% | |
| Medusa Therapeutics Limited | 83% | |
Transition Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 30, 2024 | ||||
| Seed Round | Jan 10, 2024 | ||||
| Series A | Jun 2, 2022 | ||||
| Seed | Sep 1, 2020 |
Transition Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series A |
| Magnetic Ventures | Series A, Series B |
| Taiho Ventures | Series A |
| Lifeforce Capital | Series A, Series B, Seed |
| Northpond Ventures | Series A |
| Cambridge Enterprise | Seed, Series A |
| Northpond Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
Close affiliation disclosed with University of Cambridge and Harvard.
- Jun 2, 2022
Raised $50M led by Northpond Ventures
Transition Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transition Bio's valuation, stock price, and market status.